FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128521569> ?p ?o ?g. }

• W3128521569 endingPage "352" @default.
• W3128521569 startingPage "343" @default.
• W3128521569 abstract "Healthcare workers exposure to antineoplastic drugs can lead to adverse health effects. Guidelines promote the safe handling of antineoplastic drugs, but no safe exposure limit was determined. Regular surface sampling contributes to ensuring workers safety.A cross-sectional monitoring is conducted once a year with voluntary Canadian centers, since 2010. Twelve standardized sampling sites were sampled. Samples were analyzed by high performance mass coupled liquid chromatography. The limits of detection (in ng/cm2) were: 0.001 for cyclophosphamide and gemcitabine; 0.3 for docetaxel and ifosfamide; 0.04 for 5-fluorouracil and paclitaxel; 0.003 for irinotecan; 0.002 for methotrexate; 0.01 for vinorelbine.The surfaces from 109 centers were sampled between 01/01/2020-18/06/2020. Twenty-six centers delayed their participation because of the COVID-19 pandemic. 1217 samples were analyzed. Surfaces were frequently contaminated with cyclophosphamide (34% positive, 75th percentile 0.00165 ng/cm2) and gemcitabine (16% and <0.001 ng/cm2). The armrest of patient treatment chairs (84% to at least one drug), the front grille inside the biological safety cabinet (BSC) (73%) and the floor in front of the BSC (55%) were frequently contaminated. Centers that prepared ≥5000 antineoplastic drugs annually had higher concentration of cyclophosphamide on their surfaces (p < 0.0001). Contamination measured on the surfaces was reduced from 2010 to 2020.This large-scale study showed reproducible long term follow up of the contamination of standardized sites of Canadian centers and a reduction in surface contamination from 2010 to 2020. Periodic surface sampling help centers meet their continuous improvements goals to reduce exposure as much as possible. The COVID-19 pandemic had a limited impact on the program." @default.
• W3128521569 created "2021-02-15" @default.
• W3128521569 creator A5008400147 @default.
• W3128521569 creator A5039353328 @default.
• W3128521569 creator A5044971453 @default.
• W3128521569 creator A5068129901 @default.
• W3128521569 creator A5089220184 @default.
• W3128521569 date "2021-02-10" @default.
• W3128521569 modified "2023-10-17" @default.
• W3128521569 title "Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program" @default.
• W3128521569 cites W1979876043 @default.
• W3128521569 cites W2016709601 @default.
• W3128521569 cites W2166370227 @default.
• W3128521569 cites W2327851062 @default.
• W3128521569 cites W2334374283 @default.
• W3128521569 cites W2371218808 @default.
• W3128521569 cites W2525506605 @default.
• W3128521569 cites W2553848217 @default.
• W3128521569 cites W2607958847 @default.
• W3128521569 cites W2744887453 @default.
• W3128521569 cites W2749886505 @default.
• W3128521569 cites W2800105964 @default.
• W3128521569 cites W2897965015 @default.
• W3128521569 cites W2908571515 @default.
• W3128521569 cites W2915662961 @default.
• W3128521569 cites W2938462944 @default.
• W3128521569 cites W2947527220 @default.
• W3128521569 cites W2966864262 @default.
• W3128521569 cites W2969810241 @default.
• W3128521569 cites W2972410233 @default.
• W3128521569 cites W2981223732 @default.
• W3128521569 cites W3010072035 @default.
• W3128521569 cites W3010156616 @default.
• W3128521569 cites W3017176883 @default.
• W3128521569 cites W3020903228 @default.
• W3128521569 cites W3040490155 @default.
• W3128521569 doi "https://doi.org/10.1177/1078155221992103" @default.
• W3128521569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33567975" @default.
• W3128521569 hasPublicationYear "2021" @default.
• W3128521569 type Work @default.
• W3128521569 sameAs 3128521569 @default.
• W3128521569 citedByCount "8" @default.
• W3128521569 countsByYear W31285215692021 @default.
• W3128521569 countsByYear W31285215692022 @default.
• W3128521569 countsByYear W31285215692023 @default.
• W3128521569 crossrefType "journal-article" @default.
• W3128521569 hasAuthorship W3128521569A5008400147 @default.
• W3128521569 hasAuthorship W3128521569A5039353328 @default.
• W3128521569 hasAuthorship W3128521569A5044971453 @default.
• W3128521569 hasAuthorship W3128521569A5068129901 @default.
• W3128521569 hasAuthorship W3128521569A5089220184 @default.
• W3128521569 hasConcept C112570922 @default.
• W3128521569 hasConcept C121608353 @default.
• W3128521569 hasConcept C126322002 @default.
• W3128521569 hasConcept C126838900 @default.
• W3128521569 hasConcept C136229726 @default.
• W3128521569 hasConcept C18903297 @default.
• W3128521569 hasConcept C197934379 @default.
• W3128521569 hasConcept C2776694085 @default.
• W3128521569 hasConcept C2776755627 @default.
• W3128521569 hasConcept C2776811147 @default.
• W3128521569 hasConcept C2777501473 @default.
• W3128521569 hasConcept C2777506904 @default.
• W3128521569 hasConcept C2777899217 @default.
• W3128521569 hasConcept C2778119113 @default.
• W3128521569 hasConcept C2778971682 @default.
• W3128521569 hasConcept C2780192828 @default.
• W3128521569 hasConcept C2781190966 @default.
• W3128521569 hasConcept C2909231917 @default.
• W3128521569 hasConcept C3017814627 @default.
• W3128521569 hasConcept C33070731 @default.
• W3128521569 hasConcept C71924100 @default.
• W3128521569 hasConcept C86803240 @default.
• W3128521569 hasConcept C98274493 @default.
• W3128521569 hasConceptScore W3128521569C112570922 @default.
• W3128521569 hasConceptScore W3128521569C121608353 @default.
• W3128521569 hasConceptScore W3128521569C126322002 @default.
• W3128521569 hasConceptScore W3128521569C126838900 @default.
• W3128521569 hasConceptScore W3128521569C136229726 @default.
• W3128521569 hasConceptScore W3128521569C18903297 @default.
• W3128521569 hasConceptScore W3128521569C197934379 @default.
• W3128521569 hasConceptScore W3128521569C2776694085 @default.
• W3128521569 hasConceptScore W3128521569C2776755627 @default.
• W3128521569 hasConceptScore W3128521569C2776811147 @default.
• W3128521569 hasConceptScore W3128521569C2777501473 @default.
• W3128521569 hasConceptScore W3128521569C2777506904 @default.
• W3128521569 hasConceptScore W3128521569C2777899217 @default.
• W3128521569 hasConceptScore W3128521569C2778119113 @default.
• W3128521569 hasConceptScore W3128521569C2778971682 @default.
• W3128521569 hasConceptScore W3128521569C2780192828 @default.
• W3128521569 hasConceptScore W3128521569C2781190966 @default.
• W3128521569 hasConceptScore W3128521569C2909231917 @default.
• W3128521569 hasConceptScore W3128521569C3017814627 @default.
• W3128521569 hasConceptScore W3128521569C33070731 @default.
• W3128521569 hasConceptScore W3128521569C71924100 @default.
• W3128521569 hasConceptScore W3128521569C86803240 @default.
• W3128521569 hasConceptScore W3128521569C98274493 @default.
• W3128521569 hasIssue "2" @default.

• next